Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Diseases × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 94 Carcinoma, Renal Cell 67 Neoplasm Metastasis 41 Neoplasms 34 Neuroendocrine Tumors 31 Kidney Neoplasms 24 Recurrence 16 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Tuberous Sclerosis 15 Head and Neck Neoplasms 14 Triple Negative Breast Neoplasms 13 Lymphoma, Mantle-Cell 13 Lymphoma 12 Hodgkin Disease 12 Glioblastoma 12 Colorectal Neoplasms 12 Carcinoma, Hepatocellular 12 Brain Neoplasms 12 Sarcoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Pancreatic Neoplasms 11 Lymphoma, Large B-Cell, Diffuse 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Carcinoma, Neuroendocrine 10 Waldenstrom Macroglobulinemia 9 Stomach Neoplasms 9 Multiple Myeloma 9 Lymphoma, Follicular 9 Lung Neoplasms 9

Interventions

binimetinib 2 Watchful Waiting 2 Aminolevulinic Acid 2 palbociclib 1 methyl 5-aminolevulinate 1 ipatasertib 1 exemestane 1 encorafenib 1 baricitinib 1 atezolizumab 1 Vemurafenib 1 VP-102 1 Spironolactone 1 Sodium Chloride 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Paclitaxel 1 Low-Level Light Therapy 1 Leuprolide 1 Injections, Intradermal 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Equipment and Supplies 1 Docetaxel 1 Dacarbazine 1 Cetuximab 1 Capecitabine 1 Cantharidin 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01743560 2019-07-18

4EVERUK

Novartis

Phase 4 Completed

52 enrolled 16 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡